The rise of copyright’s blockbuster initially drove a boom for major pharmaceutical companies, but recent changes present a uncertain scenario for shareholders. Off-patent competitors are eating into revenue, and https://haseebixts998187.blognody.com/50208710/sildenafil-and-pharma-a-volatile-investment